Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Clin Lab Med ; 26(2): 505-13, x, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16815463

RESUMO

We are on the cusp of exciting new developments in vaccine biology. The use of DNA constructs allows virtually unlimited access to previously inaccessible organisms. Next-generation adjuvants will boost innate and acquired immunity, and will provide protection from infection with any potential biowarfare organism. We are limited only by our imaginations in the construction of a protective armamentarium.


Assuntos
Guerra Biológica , Bioterrorismo , Imunoterapia/tendências , Vacinação/tendências , Animais , Humanos
2.
Brain Res ; 1070(1): 24-30, 2006 Jan 27.
Artigo em Inglês | MEDLINE | ID: mdl-16405925

RESUMO

Overactivation of the PI3 kinase/Akt pathway plays an essential role in the development and progression of various tumors. Akt is a key component of this pathway and hyperactivated in different tumors including neuroblastoma and glioma. In the present study, we tested the therapeutic efficacy of siRNA targeting Akt in inducing apoptotic cell death in NBFL cells (a human neuroblastoma cell line) subjected to anoxia/reoxygenation (A/R), a process that has been shown to modulate growth and progression of malignant tumors. We observed that siRNA targeting Akt effectively induced apoptotic cell death in NBFL cells (as determined by TUNEL assay and activated caspase-3 immunoreactivity) under normoxic conditions, an effect that was greatly enhanced under conditions of A/R. These findings underscore the importance of Akt signaling in promoting survival of neuroblastoma cells and may have potential therapeutic applications.


Assuntos
Apoptose , Hipóxia Celular , Neuroblastoma/fisiopatologia , Proteínas Proto-Oncogênicas c-akt/genética , Interferência de RNA , Linhagem Celular Tumoral , Humanos , Dados de Sequência Molecular , Neuroblastoma/genética , Neuroblastoma/metabolismo , Neuroblastoma/patologia , Oxigênio/farmacologia , Proteínas Proto-Oncogênicas c-akt/metabolismo , Regulação para Cima
3.
Biochem Biophys Res Commun ; 332(3): 688-96, 2005 Jul 08.
Artigo em Inglês | MEDLINE | ID: mdl-15907801

RESUMO

Comprehensive knowledge of the gene expression changes induced by hemorrhage in vital organs will greatly improve prognosis and therapy. Therefore, we used a mouse model of non-resuscitated hemorrhagic shock to study the pattern of stress-induced genes in liver at 1, 4, and 24 h following surgery. Hepatic injury was confirmed by assessment of liver injury markers and apoptotic cell death. We found that a variety of stress-regulated genes were differentially expressed, including seven genes that have not been reported previously as being regulated by hemorrhagic shock: ATF-2, alphaB-crystallin, GADD45, GADD45beta, Mdm2, p21Waf1, and TRPM-2. The changes in mRNA levels of the transcription factors AP-1, Egr-1, HSF-1, and NF-kappaB were transient but protein expression was noticeable at later time points. Our findings show that oxidative stress causes immediate upregulation of genes involved in a variety of cellular defense pathways. Complex interactions among them might determine the ultimate fate of the cell.


Assuntos
Apoptose , Expressão Gênica , Fígado/metabolismo , Fígado/patologia , Choque Hemorrágico/genética , Choque Hemorrágico/patologia , Alanina Transaminase/sangue , Animais , Aspartato Aminotransferases/sangue , Proteínas de Ciclo Celular/genética , Inibidor de Quinase Dependente de Ciclina p21 , Feminino , Perfilação da Expressão Gênica , Peroxidação de Lipídeos , Fígado/lesões , Camundongos , Camundongos Endogâmicos BALB C , Proteínas Nucleares/genética , Análise de Sequência com Séries de Oligonucleotídeos , Estresse Oxidativo/genética , Proteínas Proto-Oncogênicas/genética , Proteínas Proto-Oncogênicas c-mdm2 , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Choque Hemorrágico/metabolismo , Fatores de Transcrição/metabolismo , Cadeia B de alfa-Cristalina/genética
4.
Shock ; 23(6): 539-42, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15897807

RESUMO

We have previously demonstrated that the administration of recombinant human interleukin-11 (rhIL-11) during resuscitation improves the blood pressure in a rodent model of hemorrhagic shock. The purpose of this study was to determine whether the effects of rhIL-11 could be reproduced in a large animal model and to elucidate the impact of rhIL-11 administration on the intravascular volume status and the degree of third space fluid loss after resuscitation. A 40% blood volume hemorrhage was induced in swine (n = 45, weight of 25-35 kg) followed by a 1-h shock period and resuscitation with 0.9% sodium chloride (three times the shed blood volume). The animals were randomized to receive sham hemorrhage (group I, sham); sham hemorrhage and 50 microg/kg rhIL-11 (group II, sham + IL-11); no drug (group III, saline); or 50 microg/kg rhIL-11 (group IV, IL-11). Blood and urine samples were obtained and analyzed at baseline, at the end of hemorrhaging, and thereafter once every hour. The pleural and peritoneal effusions were precisely quantified by using clinically accepted criteria. The mean arterial pressure (MAP) was higher postresuscitation (PR) in groups I, II, and IV (71.4 +/- 7.5 mmHg, 71.0 +/- 8.9 mmHg, and 72.9 +/- 12.3 mmHg, respectively) than in group III (59.9 +/- 10.9 mmHg), and the cardiac output of PR was higher in group IV (3.46 +/- 0.56 L/min) than in group III (2.99 +/- 0.62 L/min; P < 0.01). The difference in MAP between groups I and II became statistically significant at 40 min after rhIL-11 injection and such a difference persisted for 90 min. After resuscitation, the urine output was higher, and the urine specific gravity and third space fluid loss were lower in group IV (1434 +/- 325 mL and 1.0035, 82 +/- 21 mL) than in group III (958 +/- 390 mL and 1.0053, 125 +/- 32 mL; P < 0.05). In a porcine model of hemorrhagic shock, the administration of rhIL-11 at the start of resuscitation significantly improved the cardiac output and blood pressure. This strategy also significantly reduced the extent of third space fluid losses while also having a favorable impact on the intravascular volume status as evidenced by the improved urine output.


Assuntos
Interleucina-11/administração & dosagem , Proteínas Recombinantes/administração & dosagem , Choque Hemorrágico/tratamento farmacológico , Choque Hemorrágico/veterinária , Animais , Pressão Sanguínea , Monóxido de Carbono , Débito Cardíaco/efeitos dos fármacos , Modelos Animais de Doenças , Hemodinâmica , Interleucina-11/metabolismo , Lactatos/metabolismo , Pressão , Distribuição Aleatória , Ressuscitação , Cloreto de Sódio/farmacologia , Suínos , Fatores de Tempo
5.
Shock ; 17(6): 521-6, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12069191

RESUMO

Previous studies have suggested benefit of mild hypothermia during hemorrhagic shock (HS). This finding needs additional confirmation and investigation into possible mechanisms. Proinflammatory cytokines are mediators of multiple organ failure following traumatic hemorrhagic shock and resuscitation. We hypothesized that mild hypothermia would improve survival from HS and may affect the pro- and anti-inflammatory cytokine response in a rat model of uncontrolled HS. Under light halothane anesthesia, uncontrolled HS was induced by blood withdrawal of 3 mL/100 g over 15 min followed by tail amputation. Hypotensive (limited) fluid resuscitation (to prevent mean arterial pressure [MAP] from decreasing below 40 mmHg) with blood was started at 30 min and continued to 90 min. After hemostasis and resuscitation with initially shed blood and Ringer's solution, the rats were observed for 72 h. The animals were randomized into two HS groups (n = 10 each): normothermia (38 degrees C +/- 0.5 degrees C) and mild hypothermia (34 degrees C +/- 0.5 degrees C) from HS 30 min until resuscitation time (RT) 60 min; and a sham group (n = 3). Venous blood samples were taken at baseline, RT 60 min, and days 1, 2, and 3. Serum interleukin (IL)-1beta, IL-6, IL-10, and tumor necrosis factor (TNF)-alpha concentrations were quantified by ELISA. Values are expressed as median and interquartile range. Survival time by life table analysis was greater in the hypothermia group (P = 0.04). Survival rates to 72 h were 1 of 10 vs. 6 of 10 in the normothermia vs. hypothermia groups, respectively (P = 0.057). All cytokine concentrations were significantly increased from baseline at RT 60 min in both HS groups, but not in the shams. At RT 60 min, in the normothermia vs. hypothermia groups, respectively, IL-1beta levels were 185 (119-252) vs. 96 (57-135) pg/mL (P = 0.15); IL-6 levels were 2242 (1903-3777) vs. 1746 (585-2480) pg/mL (P = 0.20); TNF-alpha levels were 97 (81-156) vs. 394 (280-406) pg/mL (P= 0.02); and IL-10 levels were 1.7 (0-13.3) vs. 15.8 (1.9-23.0) pg/mL (P = 0.09). IL-10 remained increased until day 3 in the hypothermia group. High IL-1beta levels (>100 pg/mL) at RT 60 min were associated with death before 72 h (odds ratio 66, C.I. 3.5-1255). We conclude that mild hypothermia improves survival time after uncontrolled HS. Uncontrolled HS induces a robust proinflammatory cytokine response. The unexpected increase in TNF-alpha with hypothermia deserves further investigation.


Assuntos
Citocinas/sangue , Hipotermia Induzida , Choque Hemorrágico/imunologia , Choque Hemorrágico/terapia , Animais , Mediadores da Inflamação/metabolismo , Interleucina-1/sangue , Interleucina-10/sangue , Interleucina-6/sangue , Masculino , Ratos , Ratos Sprague-Dawley , Ressuscitação , Choque Hemorrágico/fisiopatologia , Fator de Necrose Tumoral alfa/metabolismo
6.
Shock ; 17(4): 322-8, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11954835

RESUMO

The etiology of many end-organ problems associated with hemorrhage has been attributed to the inflammatory response to hemorrhage. In a murine model of nonresuscitated, fixed-volume hemorrhage, we sought to elucidate the role that hemorrhagic insult alone plays in the generation of the early inflammatory cascade. Differences could be appreciated as early as 1 h post-hemorrhage, with consistent differences detected by 3 h in all of the major cytokine genes studied. Significant upregulation of IL-1beta , IL-6, TNF-alpha, and IL-10 mRNA expression was observed in both the liver and lung samples of mice subjected to fixed-volume hemorrhage when compared with sham-hemorrhaged mice. The cyclooxygenase-2 (COX-2) and inducible nitric oxide synthetase (iNOS) genes also were upregulated in the livers and lungs of hemorrhaged mice. Finally, expression of the genes that encode the Toll-like receptors (TLR)-2 and -4 was increased by hemorrhage. Taken collectively, these data demonstrate that the initial inflammatory cascade associated with hemorrhage occurs within hours after the initial hemorrhagic event, and can be associated with significant modulation of expression of key pro- and anti-inflammatory cytokine, enzyme, and TLR genes, suggesting that these may be possible new therapeutic targets.


Assuntos
Proteínas de Drosophila , Hemorragia/complicações , Hemorragia/genética , Inflamação/etiologia , Inflamação/genética , Animais , Sequência de Bases , Ciclo-Oxigenase 2 , Citocinas/genética , DNA Complementar/genética , Modelos Animais de Doenças , Feminino , Expressão Gênica , Isoenzimas/genética , Glicoproteínas de Membrana/genética , Camundongos , Camundongos Endogâmicos C57BL , Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase Tipo II , Prostaglandina-Endoperóxido Sintases/genética , Receptores de Superfície Celular/genética , Fatores de Tempo , Receptor 2 Toll-Like , Receptores Toll-Like
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA